{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["RECAP", "fragment library generation", "fragment-based drug discovery", "pharmacophore modeling", "property-based design", "protein-ligand interactions", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34422762", "DateRevised": {"Year": "2021", "Month": "08", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "02"}], "Language": ["eng"], "ELocationID": ["700802", "10.3389/fchem.2021.700802"], "Journal": {"ISSN": "2296-2646", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in chemistry", "ISOAbbreviation": "Front Chem"}, "ArticleTitle": "Non-Extensive Fragmentation of Natural Products and Pharmacophore-Based Virtual Screening as a Practical Approach to Identify Novel Promising Chemical Scaffolds.", "Pagination": {"StartPage": "700802", "MedlinePgn": "700802"}, "Abstract": {"AbstractText": ["Fragment-based drug design (FBDD) and pharmacophore modeling have proven to be efficient tools to discover novel drugs. However, these approaches may become limited if the collection of fragments is highly repetitive, poorly diverse, or excessively simple. In this article, combining pharmacophore modeling and a non-classical type of fragmentation (herein called non-extensive) to screen a natural product (NP) library may provide fragments predicted as potent, diverse, and developable. Initially, we applied retrosynthetic combinatorial analysis procedure (RECAP) rules in two versions, extensive and non-extensive, in order to deconstruct a virtual library of NPs formed by the databases Traditional Chinese Medicine (TCM), AfroDb (African Medicinal Plants database), NuBBE (Nuclei of Bioassays, Biosynthesis, and Ecophysiology of Natural Products), and UEFS (Universidade Estadual de Feira de Santana). We then developed a virtual screening (VS) using two groups of natural-product-derived fragments (extensive and non-extensive NPDFs) and two overlapping pharmacophore models for each of 20 different proteins of therapeutic interest. Molecular weight, lipophilicity, and molecular complexity were estimated and compared for both types of NPDFs (and their original NPs) before and after the VS proceedings. As a result, we found that non-extensive NPDFs exhibited a much higher number of chemical entities compared to extensive NPDFs (45,355 vs. 11,525 compounds), accounting for the larger part of the hits recovered and being far less repetitive than extensive NPDFs. The structural diversity of both types of NPDFs and the NPs was shown to diminish slightly after VS procedures. Finally, and most interestingly, the pharmacophore fit score of the non-extensive NPDFs proved to be not only higher, on average, than extensive NPDFs (56% of cases) but also higher than their original NPs (69% of cases) when all of them were also recognized as hits after the VS. The findings obtained in this study indicated that the proposed cascade approach was useful to enhance the probability of identifying innovative chemical scaffolds, which deserve further development to become drug-sized candidate compounds. We consider that the knowledge about the deconstruction degree required to produce NPDFs of interest represents a good starting point for eventual synthesis, characterization, and biological activity studies."], "CopyrightInformation": "Copyright \u00a9 2021 V\u00e1squez, Mu\u00f1oz, Duitama and Gonz\u00e1lez Barrios."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Dise\u00f1o de Productos y Procesos (GDPP), Department of Chemical Engineering, Universidad de Los Andes, Bogot\u00e1, Colombia."}, {"Identifier": [], "Affiliation": "Naturalius S.A.S, Bogot\u00e1, Colombia."}], "LastName": "V\u00e1squez", "ForeName": "Andr\u00e9s Felipe", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Biolog\u00eda Computacional y Ecolog\u00eda Microbiana (BCEM), Department of Biological Sciences, Universidad de Los Andes, Bogot\u00e1, Colombia."}, {"Identifier": [], "Affiliation": "Max Planck Tandem Group in Computational Biology, Universidad de Los Andes, Bogot\u00e1, Colombia."}], "LastName": "Mu\u00f1oz", "ForeName": "Alejandro Reyes", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Systems and Computing Engineering Department, Universidad de Los Andes, Bogot\u00e1, Colombia."}], "LastName": "Duitama", "ForeName": "Jorge", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Dise\u00f1o de Productos y Procesos (GDPP), Department of Chemical Engineering, Universidad de Los Andes, Bogot\u00e1, Colombia."}], "LastName": "Gonz\u00e1lez Barrios", "ForeName": "Andr\u00e9s", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Chem", "NlmUniqueID": "101627988", "ISSNLinking": "2296-2646"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Al-Nadaf A. H., Taha M. O. (2011). Discovery of New Renin Inhibitory Leads via Sequential Pharmacophore Modeling, QSAR Analysis, In Silico Screening and In Vitro Evaluation. J. Mol. Graphics Model. 29, 843\u2013864. 10.1016/j.jmgm.2011.02.001", "ArticleIdList": ["10.1016/j.jmgm.2011.02.001", "21376648"]}, {"Citation": "Bauer M. R., Ibrahim T. M., Vogel S. M., Boeckler F. M. (2013). Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 - A Public Library of Challenging Docking Benchmark Sets. J. Chem. Inf. Model. 53, 1447\u20131462. 10.1021/ci400115b", "ArticleIdList": ["10.1021/ci400115b", "23705874"]}, {"Citation": "Bembenek S. D., Tounge B. A., Reynolds C. H. (2009). Ligand Efficiency and Fragment-Based Drug Discovery. Drug Discov. Today 14, 278\u2013283. 10.1016/j.drudis.2008.11.007", "ArticleIdList": ["10.1016/j.drudis.2008.11.007", "19073276"]}, {"Citation": "Bohacek R. S., McMartin C., Guida W. C. (1996). The Art and Practice of Structure-Based Drug Design: A Molecular Modeling Perspective. Med. Res. Rev. 16, 3\u201350. 10.1002/(SICI)1098-1128(199601)16:1<3:AID-MED1>3.0.CO;2-6", "ArticleIdList": ["10.1002/(SICI)1098-1128(199601)16:1<3:AID-MED1>3.0.CO;2-6", "8788213"]}, {"Citation": "Borra S., Lapinskaite R., Kempthorne C., Liscombe D., McNulty J., Hudlicky T. (2018). Isolation, Synthesis, and Semisynthesis of Amaryllidaceae Constituents fromNarcissusandGalanthussp.: De Novo Total Synthesis of 2-Epi-Narciclasine. J. Nat. Prod. 81, 1451\u20131459. 10.1021/acs.jnatprod.8b00218", "ArticleIdList": ["10.1021/acs.jnatprod.8b00218", "29787267"]}, {"Citation": "Camp D., Garavelas A., Campitelli M. (2015). Analysis of Physicochemical Properties for Drugs of Natural Origin. J. Nat. Prod. 78, 1370\u20131382. 10.1021/acs.jnatprod.5b00255", "ArticleIdList": ["10.1021/acs.jnatprod.5b00255", "26039921"]}, {"Citation": "ChemAxon MarvinView. Available at: http://www.chemaxon.com/products/marvin (Accessed January 19, 2021)."}, {"Citation": "Chen Z., Li H.-l., Zhang Q.-j., Bao X.-g., Yu K.-q., Luo X.-m., et al. (2009). Pharmacophore-based Virtual Screening versus Docking-Based Virtual Screening: A Benchmark Comparison against Eight Targets. Acta Pharmacol. Sin. 30, 1694\u20131708. 10.1038/aps.2009.159", "ArticleIdList": ["10.1038/aps.2009.159", "PMC4007494", "19935678"]}, {"Citation": "Chen Y., de Bruyn Kops C., Kirchmair J. (2019). Resources for Chemical, Biological, and Structural Data on Natural Products. Prog. Chem. Org. Nat. Prod. 110, 37\u201371. 10.1007/978-3-030-14632-0_2", "ArticleIdList": ["10.1007/978-3-030-14632-0_2", "31621010"]}, {"Citation": "Debnath S., Debnath T., Majumdar S., Arunasree M. K., Aparna V. (2016). A Combined Pharmacophore Modeling, 3D QSAR, Virtual Screening, Molecular Docking, and ADME Studies to Identify Potential HDAC8 Inhibitors. Med. Chem. Res. 25, 2434\u20132450. 10.1007/s00044-016-1652-5", "ArticleIdList": ["10.1007/s00044-016-1652-5"]}, {"Citation": "Debnath S., Debnath T., Bhaumik S., Majumdar S., Kalle A. M., Aparna V. (2019). Discovery of Novel Potential Selective HDAC8 Inhibitors by Combine Ligand-Based, Structure-Based Virtual Screening and In-Vitro Biological Evaluation. Sci. Rep. 9, 1\u201314. 10.1038/s41598-019-53376-y", "ArticleIdList": ["10.1038/s41598-019-53376-y", "PMC6868012", "31748509"]}, {"Citation": "Degoey D. A., Chen H.-J., Cox P. B., Wendt M. D. (2018). Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection. J. Med. Chem. 61, 2636\u20132651. 10.1021/acs.jmedchem.7b00717", "ArticleIdList": ["10.1021/acs.jmedchem.7b00717", "28926247"]}, {"Citation": "Erlanson D. A., Fesik S. W., Hubbard R. E., Jahnke W., Jhoti H. (2016). Twenty Years on: the Impact of Fragments on Drug Discovery. Nat. Rev. Drug Discov. 15, 605\u2013619. 10.1038/nrd.2016.109", "ArticleIdList": ["10.1038/nrd.2016.109", "27417849"]}, {"Citation": "Fechner U., Schneider G. (2007). Flux (2): Comparison of Molecular Mutation and Crossover Operators for Ligand-Based De Novo Design. J. Chem. Inf. Model. 47, 656\u2013667. 10.1021/ci6005307", "ArticleIdList": ["10.1021/ci6005307", "17315990"]}, {"Citation": "Fink T., Bruggesser H., Reymond J.-L. (2005). Virtual Exploration of the Small-Molecule Chemical Universe below 160 Daltons. Angew. Chem. Int. Ed. 44, 1504\u20131508. 10.1002/anie.200462457", "ArticleIdList": ["10.1002/anie.200462457", "15674983"]}, {"Citation": "Goldmann D., Pakfeifer P., Hering S., Ecker G. F. (2015). Novel Scaffolds for Modulation of TRPV1 Identified with Pharmacophore Modeling and Virtual Screening. Future Med. Chem. 7, 243\u2013256. 10.4155/fmc.14.168", "ArticleIdList": ["10.4155/fmc.14.168", "PMC6422283", "25826358"]}, {"Citation": "Grabowski K., Baringhaus K.-H., Schneider G. (2008). Scaffold Diversity of Natural Products: Inspiration for Combinatorial Library Design. Nat. Prod. Rep. 25, 892\u2013904. 10.1039/b715668p", "ArticleIdList": ["10.1039/b715668p", "18820757"]}, {"Citation": "Gruening B., Patel H. (2012). Fragmenter v.1.0. Available at: https://github.com/bgruening/galaxytools/blob/master/chemicaltoolbox/fragmenter/fragmenter.py (Accessed January 19, 2021)."}, {"Citation": "Hall D. R., Kozakov D., Whitty A., Vajda S. (2015). Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery. Trends Pharmacol. Sci. 36, 724\u2013736. 10.1016/j.tips.2015.08.003", "ArticleIdList": ["10.1016/j.tips.2015.08.003", "PMC4640985", "26538314"]}, {"Citation": "Harvey A. L., Edrada-ebel R., Quinn R. J. (2015). The Re-emergence of Natural Products for Drug Discovery in the Genomics Era. Nat. Rev. Drug Discov. 14, 111\u2013129. 10.1038/nrd4510", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "Haustedt L. O., Siems K. (2016). \u201cThe Role of Natural Products in Drug Discovery: Examples of Marketed Drugs,\u201d In Small Molecule Medicinal Chemistry: Strategies and Technologies. Hoboken, New Jersey: John Wiley and Sons, Inc., 381. 10.1002/9781118695692.part5", "ArticleIdList": ["10.1002/9781118695692.part5"]}, {"Citation": "Higueruelo A. P., Schreyer A., Bickerton G. R. J., Blundell T. L., Pitt W. R. (2012). What Can We Learn from the Evolution of Protein-Ligand Interactions to Aid the Design of New Therapeutics? PLoS One 7, e51742\u20138. 10.1371/journal.pone.0051742", "ArticleIdList": ["10.1371/journal.pone.0051742", "PMC3519888", "23240060"]}, {"Citation": "Hilbig M., Rarey M. (2015). MONA 2: A Light Cheminformatics Platform for Interactive Compound Library Processing. J. Chem. Inf. Model. 55, 2071\u20132078. 10.1021/acs.jcim.5b00292", "ArticleIdList": ["10.1021/acs.jcim.5b00292", "26389652"]}, {"Citation": "Hilbig M., Urbaczek S., Groth I., Heuser S., Rarey M. (2013). MONA - Interactive Manipulation of Molecule Collections. J. Cheminform. 5, 1\u201310. 10.1186/1758-2946-5-38", "ArticleIdList": ["10.1186/1758-2946-5-38", "PMC3849754", "23985157"]}, {"Citation": "Hopkins A. L., Keser\u00fc G. M., Leeson P. D., Rees D. C., Reynolds C. H. (2014). The Role of Ligand Efficiency Metrics in Drug Discovery. Nat. Rev. Drug Discov. 13, 105\u2013121. 10.1038/nrd4163", "ArticleIdList": ["10.1038/nrd4163", "24481311"]}, {"Citation": "Hung A. W., Ramek A., Wang Y., Kaya T., Wilson J. A., Clemons P. A., et al. (2011). Route to Three-Dimensional Fragments Using Diversity-Oriented Synthesis. Proc. Natl. Acad. Sci. 108, 6799\u20136804. 10.1073/pnas.1015271108", "ArticleIdList": ["10.1073/pnas.1015271108", "PMC3084099", "21482811"]}, {"Citation": "Irwin J. J., Shoichet B. K. (2005). ZINC \u2212 A Free Database of Commercially Available Compounds for Virtual Screening. J. Chem. Inf. Model. 45, 177\u2013182. 10.1021/ci049714+", "ArticleIdList": ["10.1021/ci049714+", "PMC1360656", "15667143"]}, {"Citation": "Irwin J. J., Sterling T., Mysinger M. M., Bolstad E. S., Coleman R. G. (2012). ZINC: A Free Tool to Discover Chemistry for Biology. J. Chem. Inf. Model. 52, 1757\u20131768. 10.1021/ci3001277", "ArticleIdList": ["10.1021/ci3001277", "PMC3402020", "22587354"]}, {"Citation": "Kahraman A., Thornton J. M. (2008). \u201cMethods to Characterize the Structure of Enzyme Binding Sites,\u201d in In Computational Structural Biology: Methods & Applications. Editors Schwede T., Peitsch M. C. (Singapore: World Scientific Pub. Co.)), 189\u2013221. 10.1142/9789812778789_0008", "ArticleIdList": ["10.1142/9789812778789_0008"]}, {"Citation": "K\u00f6ster H., Craan T., Brass S., Herhaus C., Zentgraf M., Neumann L., et al. (2011). A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin crystal Structures with Various Fragment Chemotypes. J. Med. Chem. 54, 7784\u20137796. 10.1021/jm200642w", "ArticleIdList": ["10.1021/jm200642w", "21972967"]}, {"Citation": "Laggner C., Wolber G., Kirchmair J., Schuster D., Langer T. (2008). Chapter 3. Pharmacophore-Based Virtual Screening in Drug Discovery. Chemoinf. Approaches Virtual Screen., 76\u2013119. 10.1039/9781847558879-00076", "ArticleIdList": ["10.1039/9781847558879-00076"]}, {"Citation": "Langer T., Wolber G. (2006). \u201cExtracting Pharmacophores from Bio-Active Molecules,\u201d In Virtual ADMET Assessment In Target Selection And Maturation. Washington, DC, EEUU: American Chemical Society, 133\u2013147."}, {"Citation": "Lanz J., Riedl R. (2015). Merging Allosteric and Active Site Binding Motifs: De Novo Generation of Target Selectivity and Potency via Natural-Product-Derived Fragments. ChemMedChem. 10, 451\u2013454. 10.1002/cmdc.201402478", "ArticleIdList": ["10.1002/cmdc.201402478", "PMC4506557", "25487909"]}, {"Citation": "Laskowski R. A., Luscombe N. M., Swindells M. B., Thornton J. M. (1996). Protein Clefts in Molecular Recognition and Function. Protein Sci. 5, 2438\u20132452. 10.1002/pro.5560051206", "ArticleIdList": ["10.1002/pro.5560051206", "PMC2143314", "8976552"]}, {"Citation": "Leeson P. D., Springthorpe B. (2007). The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry. Nat. Rev. Drug Discov. 6, 881\u2013890. 10.1038/nrd2445", "ArticleIdList": ["10.1038/nrd2445", "17971784"]}, {"Citation": "Lewell X. Q., Judd D. B., Watson S. P., Hann M. M. (1998). RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. J. Chem. Inf. Comput. Sci. 38, 511\u2013522. 10.1021/ci970429i", "ArticleIdList": ["10.1021/ci970429i", "9611787"]}, {"Citation": "Markt P., Schuster D., Langer T. (2011). Pharmacophore Models for Virtual Screening. Virtual Screen., 115\u2013152. 10.1002/9783527633326.ch5", "ArticleIdList": ["10.1002/9783527633326.ch5"]}, {"Citation": "Metzler W. J., Claus B. L., McDonnell P. A., Johnson S. R., Goldfarb V., Davis M. E., et al. (2008). Application of Protein-Ligand NOE Matching to the Rapid Evaluation of Fragment Binding Poses. Fragment-Based Drug Discov., 99\u2013133. 10.1002/9780470721551.ch5", "ArticleIdList": ["10.1002/9780470721551.ch5"]}, {"Citation": "Morrison C. N., Prosser K. E., Stokes R. W., Cordes A., Metzler-Nolte N., Cohen S. M. (2020). Expanding Medicinal Chemistry into 3D Space: Metallofragments as 3D Scaffolds for Fragment-Based Drug Discovery. Chem. Sci. 11, 1216\u20131225. 10.1039/c9sc05586j", "ArticleIdList": ["10.1039/c9sc05586j", "PMC8148059", "34123246"]}, {"Citation": "Nising C. F., Br\u00e4se S. (2008). Highlights in Steroid Chemistry: Total Synthesis versus Semisynthesis. Angew. Chem. Int. Ed. 47, 9389\u20139391. 10.1002/anie.200803720", "ArticleIdList": ["10.1002/anie.200803720", "18846533"]}, {"Citation": "Ntie-Kang F., Zofou D., Babiaka S. B., Meudom R., Scharfe M., Lifongo L. L., et al. (2013). AfroDb: a Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants. PLoS One 8, e78085. 10.1371/journal.pone.0078085", "ArticleIdList": ["10.1371/journal.pone.0078085", "PMC3813505", "24205103"]}, {"Citation": "Over B., Wetzel S., Gr\u00fctter C., Nakai Y., Renner S., Rauh D., et al. (2012). Natural-product-derived Fragments for Fragment-Based Ligand Discovery. Nat. Chem. 5, 21\u201328. 10.1038/nchem.1506", "ArticleIdList": ["10.1038/nchem.1506", "23247173"]}, {"Citation": "Rizzi A., Fioni A. (2008). Virtual Screening Using PLS Discriminant Analysis and ROC Curve Approach: an Application Study on PDE4 Inhibitors. J. Chem. Inf. Model. 48, 1686\u20131692. 10.1021/ci800072r", "ArticleIdList": ["10.1021/ci800072r", "18671384"]}, {"Citation": "Sander T., Freyss J., Von Korff M., Rufener C. (2015). DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis. J. Chem. Inf. Model. 55, 460\u2013473. 10.1021/ci500588j", "ArticleIdList": ["10.1021/ci500588j", "25558886"]}, {"Citation": "Sanders M. P. A., McGuire R., Roumen L., de Esch I. J. P., de Vlieg J., Klomp J. P. G., et al. (2012). From the Protein's Perspective: the Benefits and Challenges of Protein Structure-Based Pharmacophore Modeling. Med. Chem. Commun. 3, 28\u201338. 10.1039/c1md00210d", "ArticleIdList": ["10.1039/c1md00210d"]}, {"Citation": "Schade M. (2007). \u201cFragment-Based Lead Discovery by NMR,\u201d. In Frontiers In Drug Design And Discovery. Editors Rahman A., Caldwell G. W., Choudhary M. I., Player M. R. (Sharjah, U.A.E: Bentham Science Publishers Ltd.), Vol. 3, 105\u2013119."}, {"Citation": "Schaller D., \u0160ribar D., Noonan T., Deng L., Nguyen T. N., Pach S., et al. (2020). Next Generation 3D Pharmacophore Modeling. Wires Comput. Mol. Sci. 10, 1\u201320. 10.1002/wcms.1468", "ArticleIdList": ["10.1002/wcms.1468"]}, {"Citation": "Schulz M. N., Hubbard R. E. (2009). Recent Progress in Fragment-Based lead Discovery. Curr. Opin. Pharmacol. 9, 615\u2013621. 10.1016/j.coph.2009.04.009", "ArticleIdList": ["10.1016/j.coph.2009.04.009", "19477685"]}, {"Citation": "Scior T., Bender A., Tresadern G., Medina-Franco J. L., Mart\u00ednez-Mayorga K., Langer T., et al. (2012). Recognizing Pitfalls in Virtual Screening: a Critical Review. J. Chem. Inf. Model. 52, 867\u2013881. 10.1021/ci200528d", "ArticleIdList": ["10.1021/ci200528d", "22435959"]}, {"Citation": "Scoffin R., Slater M. (2015). Virtual Elaboration of Fragment Ideas\u202f: Growing , Merging and Linking Fragments with Realistic Chemistry. Drug Discov. Dev. Deliv. 7, 2\u20135."}, {"Citation": "Stocks M. J., Wilden G. R. H., Pairaudeau G., Perry M. W. D., Steele J., Stonehouse J. P. (2009). A Practical Method for Targeted Library Design Balancing lead-like Properties with Diversity. ChemMedChem. 4, 800\u2013808. 10.1002/cmdc.200900050", "ArticleIdList": ["10.1002/cmdc.200900050", "19360802"]}, {"Citation": "Teodoro M., Muegge I. (2011). BIBuilder: Exhaustive Searching for De Novo Ligands. Mol. Inf. 30, 63\u201375. 10.1002/minf.201000122", "ArticleIdList": ["10.1002/minf.201000122", "27467878"]}, {"Citation": "Toba S., Srinivasan J., Maynard A. J., Sutter J., Court T., Diego S. (2006). Using Pharmacophore Models to Gain Insight into Structural Binding and Virtual Screening\u202f: An Application Study with CDK2 and Human DHFR. 728\u2013735. Available at: http://pubs.acs.org/doi/abs/10.1021/ci050410c(Accessed January 19, 2021). ", "ArticleIdList": ["10.1021/ci050410c", "16563003"]}, {"Citation": "Tyagi M., Begnini F., Poongavanam V., Doak B. C., Kihlberg J. (2020). Drug Syntheses beyond the Rule of 5. Chem. Eur. J. 26, 49\u201388. 10.1002/chem.201902716", "ArticleIdList": ["10.1002/chem.201902716", "31483909"]}, {"Citation": "V\u00e1squez A. F., Gonz\u00e1lez Barrios A. (2019). Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment \u201cRescue\u201d Effect. Front. Chem. 7, 1\u20137. 10.3389/fchem.2019.00564", "ArticleIdList": ["10.3389/fchem.2019.00564", "PMC6710606", "31482085"]}, {"Citation": "V\u00e1squez A. F., Reyes Mu\u00f1oz A., Duitama J., Gonz\u00e1lez Barrios A. (2020). Discovery of New Potential CDK2/VEGFR2 Type II Inhibitors by Fragmentation and Virtual Screening of Natural Products. J. Biomol. Struct. Dyn. 0, 1\u201315. 10.1080/07391102.2020.1763839", "ArticleIdList": ["10.1080/07391102.2020.1763839", "32362218"]}, {"Citation": "Venkatraman V., P\u00e9rez-Nueno V. I., Mavridis L., Ritchie D. W., Nancy I., Est G. (2010, Comprehensive Comparison of Ligand-Based Virtual Screening Tools against the DUD Data Set Reveals Limitations of Current 3D Methods, J. Chem. Inf. Model., 50. 2079\u20132093. Washington, DC, EEUU: ACS Publications). Pubs.Acs.Org. Available at: http://pubs.acs.org/doi/abs/10.1021/ci100263p%5Cnpapers2://publication/uuid/49C738DA-F463-43AD-987A-D70D6A8EC7DC. 10.1021/ci100263p\n", "ArticleIdList": ["10.1021/ci100263p%5Cnpapers2://publication/uuid/49C738DA-F463-43AD-987A-D70D6A8EC7DC", "10.1021/ci100263p", "21090728"]}, {"Citation": "Wallach I. (2011). Pharmacophore Inference and its Application to Computational Drug Discovery. Drug Dev. Res. 72, 17\u201325. 10.1002/ddr.20398", "ArticleIdList": ["10.1002/ddr.20398"]}, {"Citation": "Wolber G., Langer T. (2005). LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters. J. Chem. Inf. Model. 45, 160\u2013169. 10.1021/ci049885e", "ArticleIdList": ["10.1021/ci049885e", "15667141"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "27"}, {"Year": "2021", "Month": "6", "Day": "28"}, {"Year": "2021", "Month": "8", "Day": "23", "Hour": "6", "Minute": "36"}, {"Year": "2021", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34422762", "PMC8377161", "10.3389/fchem.2021.700802", "700802"]}}], "PubmedBookArticle": []}